Regen Biopharma Inc (RGBP) Stock Price & Analysis
Regen Biopharma Inc (RGBP) rose 0.00% to USD 0 as of July 25, 2026 at 04:56 UTC, according to Nexqual real-time market data.
RGBP last closed at USD 0; the session ranged USD 0–0 on volume of 5,610,068 shares. Market capitalization is —, with a 52-week range of USD 0–0.1 (OID). Source: Nexqual, July 25, 2026 at 04:56 UTC.
Key Statistics (as of July 25, 2026 at 04:56 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0.1 |
| Volume | 5,610,068 shares |
| Market Cap | — |
| Exchange | OID |
Technical Analysis (RGBP)
Nexqual's technical model rates RGBP "NEUTRAL" based on 2 bullish and 3 bearish signals across 125 daily candles, as of July 25, 2026 at 04:56 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 48.65 (neutral) |
| vs SMA50 | Below (USD 0) |
| MACD | -0 (negative) |
From Regen Biopharma Inc's Latest SEC 10-K Filing (filed 2025-12-30)
Key Strengths & Strategy (as disclosed to the SEC)
- After testing in animals, an Investigational New Drug Application ("IND") must be filed with the FDA to obtain authorization for human testing.
- No action can be taken to market any therapeutic product in the United States until an appropriate New Drug Application ("NDA") or Biologic License Application ("BLA") or has been approved by the FDA.
- The NR2F6 nuclear receptor has been identified as a potentially very important immune cell inhibitor (an immune checkpoint) and cancer stem cell differentiator.   DiffronC: This drug is intended to use our proprietary siRNA in vivo to inhibit cancer growth and activate T cells.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RGBPP | Regen Biopharma, Inc. | USD 0 | ▲ 28.57% |
| GGII | Green Globe International, Inc. | USD 0 | ▲ 0% |
| TGGI | Trans Global Group, Inc. | USD 0 | ▲ 0% |
| KYNC | KYN Capital Group, Inc. | USD 0 | ▲ 0% |
| WDLF | Decentral Life, Inc. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 04:56 UTC. This page is informational and not investment advice.